Azithromycin: Immunomodulatory and Antiviral Properties for SARS-CoV-2 Infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azithromycin: Immunomodulatory and Antiviral Properties for SARS-CoV-2 Infection
Authors
Keywords
Antiviral, Azithromycin, COVID-19, Immunomodulatory, SARS-CoV-2
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages 174191
Publisher
Elsevier BV
Online
2021-05-17
DOI
10.1016/j.ejphar.2021.174191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis
- (2021) Armin Bayati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?
- (2021) Devanshi Mishra et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?
- (2020) Ahmed S. Abouhashem et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
- (2020) Young-Il Kim et al. Cell Host & Microbe
- Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19
- (2020) Bharat Damle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- Androgen sensitivity gateway to COVID ‐19 disease severity
- (2020) Carlos Gustavo Wambier et al. DRUG DEVELOPMENT RESEARCH
- QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
- (2020) Ehud Chorin et al. HEART RHYTHM
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- (2020) Betsy J. Barnes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome
- (2020) Elizabeth A Middleton et al. BLOOD
- In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
- (2020) Helyson Lucas Bezerra Braz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
- (2020) Samia Arshad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin
- (2020) Ilir Maraj et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats
- (2020) Qishan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
- (2020) Jean-Christophe Lagier et al. Travel Medicine and Infectious Disease
- Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2
- (2020) Axel E. Renteria et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
- (2020) Marinella Lauriola et al. CTS-Clinical and Translational Science
- Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
- (2020) Coraline Radermecker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
- (2020) Filippo Albani et al. Journal of Clinical Medicine
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process
- (2019) Dat Huu Tran et al. JOURNAL OF ANTIBIOTICS
- Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways
- (2019) Dalia Haydar et al. JOURNAL OF IMMUNOLOGY
- PTEN loss regulates alveolar epithelial cell senescence in pulmonary fibrosis depending on Akt activation
- (2019) Ting Qiu et al. Aging-US
- Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses
- (2019) Chunfeng Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities
- (2019) Xiaohong Du et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line
- (2019) Chang-Hung Kuo et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
- (2018) Satoru Eguchi et al. HYPERTENSION
- Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice
- (2018) Chung-I Lin et al. International Journal of Biological Sciences
- Angiotensin-converting enzyme in innate and adaptive immunity
- (2018) Kenneth E. Bernstein et al. Nature Reviews Nephrology
- Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry
- (2018) Weiwei Hu et al. VIROLOGY
- Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway
- (2018) Jie Wang et al. Cell Death & Disease
- Azithromycin and Chloramphenicol Diminish Neutrophil Extracellular Traps (NETs) Release
- (2017) Weronika Bystrzycka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
- (2017) Peter G Gibson et al. LANCET
- Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice
- (2016) Yi-Han Hung et al. International Journal of Biological Sciences
- Role of phosphatidylinositol-4,5-bisphosphate 3-kinase signaling in vesicular trafficking
- (2016) Sayak Bhattacharya et al. LIFE SCIENCES
- Zika virus cell tropism in the developing human brain and inhibition by azithromycin
- (2016) Hanna Retallack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
- (2016) Mandy Menzel et al. Scientific Reports
- Angiotensin-(1–7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways
- (2016) Feng Zhang et al. Scientific Reports
- Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum
- (2015) Danny W Wilson et al. BMC BIOLOGY
- Cell entry of bovine ephemeral fever virus requires activation of Src-JNK-AP1 and PI3K-Akt-NF-κB pathways as well as Cox-2-mediated PGE2/EP receptor signalling to enhance clathrin-mediated virus endocytosis
- (2015) Ching-Yuan Cheng et al. CELLULAR MICROBIOLOGY
- Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis
- (2015) Camilo Garay et al. MOLECULAR BIOLOGY OF THE CELL
- CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells
- (2015) FANG FANG et al. Oncology Letters
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- GM-CSF Induces Cyclin D1 Expression and Proliferation of Endothelial Progenitor Cells via PI3K and MAPK Signaling
- (2014) Chaolin Qiu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease
- (2014) Tian Xue et al. INHALATION TOXICOLOGY
- Paeonol inhibited TNF-α-induced GM-CSF expression in fibroblast-like synoviocytes
- (2014) Yan Li et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Ang II-AT1R Increases Cell Migration Through PI3K/AKT and NF-κB Pathways in Breast Cancer
- (2014) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Neutrophil extracellular traps promote differentiation and function of fibroblasts
- (2014) Akrivi Chrysanthopoulou et al. JOURNAL OF PATHOLOGY
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
- (2014) Jennifer Kouznetsova et al. Emerging Microbes & Infections
- Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2
- (2013) Yun Shi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation
- (2013) Manjunath B. Joshi et al. FEBS LETTERS
- Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis
- (2013) P. M. Bartold et al. INFLAMMOPHARMACOLOGY
- META060 attenuates TNF-α-activated inflammation, endothelial–monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes
- (2012) Anuradha Desai et al. ATHEROSCLEROSIS
- Targeting inflammation by modulating the Jun/AP-1 pathway
- (2011) H. B. Schonthaler et al. ANNALS OF THE RHEUMATIC DISEASES
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion
- (2011) Peter Seizer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis
- (2011) Cong-hua Wang et al. ARTHRITIS AND RHEUMATISM
- Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages
- (2011) Young-Jun Shim et al. JOURNAL OF LEUKOCYTE BIOLOGY
- EMMPRIN (CD147/basigin) mediates platelet-monocyte interactionsin vivoand augments monocyte recruitment to the vascular wall
- (2011) C. SCHULZ et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Azithromycin for Prevention of Exacerbations of COPD
- (2011) Richard K. Albert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells
- (2010) Konstantin Tsoyi et al. ATHEROSCLEROSIS
- Azithromycin induces anti-viral responses in bronchial epithelial cells
- (2010) V. Gielen et al. EUROPEAN RESPIRATORY JOURNAL
- Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia
- (2010) Martina Bosnar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
- (2010) S. Bertram et al. JOURNAL OF VIROLOGY
- Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis
- (2009) Yanke Chen et al. CANCER LETTERS
- Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
- (2009) Francesco Blasi et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started